Research Article
Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes
Table 1
Clinical characteristics of the study patients.
| | Variable | Patients | value | | With diabetes | Without diabetes |
| | Gender | | | | | Male | 26 (63.4%) | 32 (62.7%) | | | Female | 15 (36.6%) | 19 (37.3%) | 0.947 | | Age (yr) | 64.3 ± 10.3 | 62.5 ± 15.8 | 0.522 | | Diabetes duration (yr) | | | | | 3–5 years | 1 (2.4%) | 0 (0.0%) | | | >5 years | 40 (97.6%) | 0 (0.0%) | — | | Time since diagnosis of CKD | | | | | <3 years | 17 (41.5%) | 11 (21.6%) | | | 3–5 years | 6 (14.6%) | 9 (17.6%) | | | >5 years | 18 (43.9%) | 31 (60.8%) | 0.117 | | Time in hemodialysis | | | | | <3 years | 31 (75.6%) | 30 (58.8%) | | | 3–5 years | 6 (14.6%) | 9 (17.6%) | | | >5 years | 4 (9.8%) | 12 (23.5%) | 0.168 | | Systolic pressure (mmHg) | 146.3 ± 21.3 | 136.3 ± 21.5 | 0.028 | | Diastolic pressure (mmHg) | 70.2 ± 10.8 | 69.4 ± 14.8 | 0.756 | | Weight (kg) | 74.3 ± 14.8 | 68.0 ± 11.7 | 0.024 | | Height (cm) | 167.1 ± 7.2 | 168.0 ± 9.7 | 0.598 | | BMI (kg/m2) | 26.6 ± 5.2 | 24.1 ± 3.7 | 0.010 | | WC (cm) | 103.1 ± 12.2 | 94.9 ± 10.7 | 0.001 | | HC (cm) | 105.0 ± 10.3 | 100.2 ± 7.1 | 0.012 | | WHR | 1.0 ± 0.1 | 0.9 ± 0.1 | 0.021 | | Serum sclerostin (pmol/l) | 97.2 ± 46.6 | 79.7 ± 31.2 | 0.044 |
|
|
CKD, chronic kidney disease; BMI, body mass index; WC, circumference waist; HC, hip circumference; WHR, waist hip ratio.
|
